SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-131405
Filing Date
2016-11-03
Accepted
2016-11-03 16:33:10
Documents
64
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v450922_10q.htm 10-Q 512586
2 EXHIBIT 31.1 v450922_ex31-1.htm EX-31.1 10889
3 EXHIBIT 31.2 v450922_ex31-2.htm EX-31.2 10796
4 EXHIBIT 32.1 v450922_ex32-1.htm EX-32.1 6467
  Complete submission text file 0001144204-16-131405.txt   4446469

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT anip-20160930.xml EX-101.INS 1033551
6 XBRL TAXONOMY EXTENSION SCHEMA anip-20160930.xsd EX-101.SCH 40571
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anip-20160930_cal.xml EX-101.CAL 44892
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anip-20160930_def.xml EX-101.DEF 278619
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20160930_lab.xml EX-101.LAB 306203
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20160930_pre.xml EX-101.PRE 309098
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 161972132
SIC: 2834 Pharmaceutical Preparations